Shelton Capital Management Gilead Sciences, Inc. Transaction History

Shelton Capital Management

  • $4.17 Billion
  • Q1 2025

A detailed history of Shelton Capital Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Shelton Capital Management holds 150,834 shares of GILD stock, worth $16.7 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
150,834
Previous 155,582 3.05%
Holding current value
$16.7 Million
Previous $14.4 Million 17.6%
% of portfolio
0.41%
Previous 0.36%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$89.14 - $117.41 $423,236 - $557,462
-4,748 Reduced 3.05%
150,834 $16.9 Million
Q4 2024

Feb 13, 2025
SELL
$83.95 - $97.9 $324,634 - $378,579
-3,867 Reduced 2.43%
155,582 $14.4 Million
Q3 2024

Nov 14, 2024
BUY
$66.59 - $83.99 $25,304 - $31,916
380 Added 0.24%
159,449 $13.4 Million
Q2 2024

Aug 13, 2024
BUY
$63.15 - $72.88 $11,556 - $13,337
183 Added 0.12%
159,069 $10.9 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $3.65 Million - $4.45 Million
-50,955 Reduced 24.28%
158,886 $11.6 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $7.41 Million - $8.41 Million
-101,172 Reduced 32.53%
209,841 $17 Million
Q3 2023

Nov 14, 2023
BUY
$73.94 - $80.67 $3.39 Million - $3.69 Million
45,787 Added 17.26%
311,013 $23.3 Million
Q2 2023

Aug 10, 2023
BUY
$76.01 - $86.7 $4.51 Million - $5.15 Million
59,389 Added 28.85%
265,226 $20.4 Million
Q1 2023

May 11, 2023
BUY
$77.31 - $88.08 $14.2 Million - $16.1 Million
183,237 Added 810.78%
205,837 $17.1 Million
Q4 2022

Feb 13, 2023
SELL
$62.32 - $89.47 $6.4 Million - $9.19 Million
-102,683 Reduced 81.96%
22,600 $1.94 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $6.95 Million - $7.94 Million
-116,775 Reduced 48.24%
125,283 $7.73 Million
Q2 2022

Aug 11, 2022
SELL
$57.72 - $65.01 $311,457 - $350,793
-5,396 Reduced 2.18%
242,058 $15 Million
Q1 2022

May 12, 2022
BUY
$57.92 - $72.58 $630,401 - $789,960
10,884 Added 4.6%
247,454 $14.7 Million
Q4 2021

Feb 11, 2022
BUY
$64.88 - $73.64 $3.41 Million - $3.87 Million
52,511 Added 28.53%
236,570 $17.2 Million
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $281,522 - $303,731
-4,159 Reduced 2.21%
184,059 $12.9 Million
Q2 2021

Aug 12, 2021
SELL
$63.47 - $69.35 $13.1 Million - $14.3 Million
-206,814 Reduced 52.35%
188,218 $13 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $10 Million - $11.4 Million
166,793 Added 73.08%
395,032 $25.5 Million
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $1.89 Million - $2.16 Million
33,425 Added 17.16%
228,239 $13.3 Million
Q3 2020

Nov 09, 2020
BUY
$62.1 - $78.08 $1.15 Million - $1.44 Million
18,494 Added 10.49%
194,814 $12.3 Million
Q2 2020

Aug 12, 2020
BUY
$72.34 - $84.0 $2.41 Million - $2.79 Million
33,260 Added 23.25%
176,320 $13.6 Million
Q1 2020

May 13, 2020
SELL
$62.63 - $80.22 $4.57 Million - $5.85 Million
-72,910 Reduced 33.76%
143,060 $10.7 Million
Q4 2019

Feb 11, 2020
BUY
$61.62 - $67.78 $3.99 Million - $4.39 Million
64,812 Added 42.88%
215,970 $14 Million
Q3 2019

Nov 13, 2019
SELL
$62.51 - $69.0 $797,690 - $880,509
-12,761 Reduced 7.78%
151,158 $9.58 Million
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $9.48 Million - $10.6 Million
153,263 Added 1438.28%
163,919 $11.1 Million
Q1 2019

May 10, 2019
SELL
$62.53 - $70.05 $9.58 Million - $10.7 Million
-153,228 Reduced 93.5%
10,656 $164 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $1.47 Million - $1.63 Million
-20,600 Reduced 11.17%
163,884 $12.7 Million
Q2 2018

Aug 10, 2018
BUY
$64.88 - $75.68 $279,567 - $326,105
4,309 Added 2.39%
184,484 $13.1 Million
Q1 2018

May 15, 2018
BUY
$72.84 - $88.8 $446,145 - $543,900
6,125 Added 3.52%
180,175 $13.6 Million
Q4 2017

Feb 06, 2018
SELL
$71.15 - $83.52 $381,435 - $447,750
-5,361 Reduced 2.99%
174,050 $12.5 Million
Q3 2017

Nov 14, 2017
SELL
$72.11 - $85.47 $1.7 Million - $2.02 Million
-23,600 Reduced 11.62%
179,411 $14.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
46,887 Added 30.03%
203,011 $14.4 Million
Q1 2017

Nov 28, 2017
BUY
N/A
18,155 Added 13.16%
156,124 $10.6 Million
Q4 2016

Nov 29, 2017
SELL
N/A
-8,700 Reduced 5.93%
137,969 $9.88 Million
Q3 2016

Dec 06, 2017
BUY
N/A
8,700 Added 6.31%
146,669 $11.6 Million
Q3 2016

Dec 04, 2017
BUY
N/A
137,969
137,969 $9.88 Million

Others Institutions Holding GILD

# of Institutions
2,289
Shares Held
997M
Call Options Held
9.62M
Put Options Held
10M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $139B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email